On the recordNovember 30, 2011
This bill would provide an important avenue for small biotech companies to raise innovation capital.
Source
congress.govThis bill would provide an important avenue for small biotech companies to raise innovation capital.
Toomey emphasizes the importance of the legislation for small biotech funding.
Share
More from Pat Toomey
I think that there are a number of ways that you can go about creating a regulatory regime to take account of that risk.
I think Congress really has to take the time to properly evaluate the outbound CFIUS concept rather than rushing to enact legislation that is not properly vetted.
It's a budgetary gimmick that has the intent of making it possible to have a huge explosion in unrelated spending. This is not what this bill was about. We can fix it. We can do it immediately.